|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash | |||||||
| Deferred offering costs | |||||||
| Prepaid expenses | |||||||
| Marketable securities held in Trust Account | |||||||
| Total current assets | |||||||
| Restricted cash | |||||||
| Prepaid expenses - non-current | |||||||
| Total assets | |||||||
| Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |||||||
| Accrued offering costs | |||||||
| Promissory note - related party | |||||||
| Prepaid stock subscription | |||||||
| Accrued expenses | |||||||
| Accounts payable and accrued expenses | |||||||
| Class L ordinary shares derivative liability | |||||||
| Deferred underwriters discounts and commissions | |||||||
| Total current liabilities | |||||||
| Deferred underwriters fee | |||||||
| Deferred underwriting discounts and commissions | |||||||
| Total noncurrent liabilities | |||||||
| Total liabilities | |||||||
| Redeemable Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value | |||||||
| Shareholders' Deficit | |||||||
| Class A ordinary shares, $0.0001 par value; 464,000,000 shares authorized; 975,000 issued and outstanding (excluding 28,750,000 shares subject to possible redemption) | |||||||
| Accumulated deficit | |||||||
| Total Shareholders' Deficit | |||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...